FDA Reports Results of Nationwide Infant Formula Testing - Summary - MDSpire
FDA & Government News

FDA Reports Results of Nationwide Infant Formula Testing

Federal testing survey examines chemical contaminant profiles across widely used products

  • By

  • Kathryn Wighton

  • April 29, 2026

  • 3 min

Share

The FDA has completed its largest study on chemical contaminants in infant formula, testing over 300 samples from various products available in the U.S. market. The analysis yielded over 120,000 data points, assessing levels of elements like lead, mercury, and arsenic. Results indicate that most infant formula products possess either undetectable or very low levels of contaminants, reaffirming their safety. Health officials stress the importance of transparency and ongoing monitoring, aiming to enhance formula safety for vulnerable infants.

Original Source(s)

FDA Reports Results of Nationwide Infant Formula Testing

  • by Kathryn Wighton

  • April 29, 2026

Related Content

Smartwatch May Track AD Status in Children

Wearable-derived scratching measures align with disease activity and short-term treatment response in pediatric patients with atopic dermatitis.

AAP Updates Pediatric Office Emergency Readiness

Guidance addresses office readiness, recommended equipment and medications, and team communication processes for infrequent but high-acuity emergencies.

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.